Business
MedX Holdings, Inc. Announces It Has Entered Into The Pharmaceutical and Nutraceutical Wholesale Distributor Sector.
MedX Holdings, Inc. Announces It Has Entered Into The Pharmaceutical and Nutraceutical Wholesale Distributor Sector..
About this update from Medx Holdings, Inc.
[{"type":"text","content":"\n\n Cheyenne Wyoming, May 17, 2016 (GLOBE NEWSWIRE) -- MedX Holdings, Inc. (OTC PINK: MEDH) today announces MedX is in the process of becoming licensed as a Wholesale Distributor of Pharmaceuticals in the state of Alabama. As a result, the company has also entered into an Exclusive Marketing Agreement with B&B Consulting whose sales exceeded over $7,000,000 dollars in pharmaceutical sales in 2015. Mr. Hiltz, Managing Member of B&B Consulting has agreed to oversee the company’s pharmaceutical sales division. Mr. Hiltz stated “I am excited to join MedX Holdings, I believe that the combination of a public company and pharmaceutical sales just makes sense.”\n In addition, MedX has also secured an agreement with one of the largest FDA Manufacturers in the United States. Our first product that has been approved to sell is a 5% Lidocaine Ointment 50g jar. Our negotiated price allows us to have very competitive pricing to offer B&B’s current list of clients. 5% Lidocaine is a highly sought after analgesic ointment for the purpose of reducing and controlling pain. This comes at a time when our nation is riveting over the rising deaths occurring in epidemic proportion all resulting from the overuse of oral prescription pain medication. As a result, Physicians and other medical professionals are being forced to look at alternative solutions when treating pain.   Kathleen Roberton CEO of MedX Holdings stated, “It makes perfect sense to enter into Pharmaceutical and Nutraceutical sales as we build our portfolio of medial businesses. This will allow our company to produce its own revenue without being a burden to our acquisitions which add tangilble asset based value”. MedX Holdings, Inc. is a publicly trading holding company utilizing a new form of collaborative governance to create added value for its portfolio of holdings. MEDH targets the acquisitions of undervalued, turnaround medical related businesses along with products and services that benefit our partners.  Our mission is to provide a new form of governance enabling medical related businesses and product driven partners to take advantage of the power of a public company without losing management expertise.     For more information about MedX Holdings, Inc., call (877) 225-0243 or visit our web site www.medxho...